News Sanofi passes on Alnylam’s breakthrough therapy Linda Banks Alnylam, breakthrough Therapy, patisiran, rare disease, RNAi, Sanofi 0 Comment Alnylam is to forge ahead with a rare disease therapy on its own after Sanofi decided to opt Share X Sanofi passes on Alnylam’s breakthrough therapy https://pharmaphorum.com/news/sanofi-passes-alnylams-breakthrough-therapy/
Alnylam, breakthrough Therapy, patisiran, rare disease, RNAi, Sanofi
0 Comment
